by
The pace and sophistication of advances in medicine in the past two decades have necessitated a growing need for a comprehensive reference that highlights the current issues in medicine. Each volume in the Current Issues in Medicine series is a stand‐alone text that provides a broad survey of various critical topics―all accomplished in a user-friendly yet interconnected format. The series not only highlights current advances but also explores related topics such as translational medicine, precision medicine, nanomedicine, regulatory science, neglected global diseases, emerging pandemics such as COVID-19, FDA and patent law, immunotoxicology, theranostics, big data, artificial intelligence, novel imaging tools and techniques, combination drug products, and novel therapies. While bridging the gap between basic research and clinical medicine, this series provides a thorough understanding of medicine’s potential to address health problems from both the patient’s and the provider’s perspectives in a healthcare setting. Each volume is an excellent resource for medical practitioners, medical students, nurses, fellows, residents, undergraduate and graduate students, educators, venture capitalists, policymakers, biomedical researchers, and general readers. The multidisciplinary approach of the series makes it a valuable reference for health care systems, the pharmaceutical industry, academia, and governments. However, unlike other series on medicine or medical texts, this series focuses on current trends, perspectives, and issues in medicine that are central to healthcare delivery in the 21st century.
The first two volumes in this series focus on the current issues in basic medical sciences, subjects that are fundamental to the practice of medicine. These subjects, traditionally taught in the first two years of medical school that precede clinical instruction, provide a core of basic knowledge crucial for the success in clinical medicine during rotations, training, and medical practice. The subsequent volumes are dedicated to clinical topics in medicine. While recognizing how expansive and multifaceted medicine is, this volume is not a textbook that provides comprehensive information on medical specialties: It addresses crucial recent advances in surgical and medical specialties. Specifically, it integrates the knowledge and experience of experts from academia and practicing surgeons. Medical practitioners today continue to improve upon techniques and technologies to provide for safer, more precise, less invasive, and accurate procedures for patients―a direct consequence of advances in technological breakthroughs from a variety of medical and engineering fields. Hence, it is imperative that surgeons and medical practitioners stay current with these latest advances in their respective specialties to render modern patient care. Given this backdrop, the specific topics covered in this volume and the expertise of the contributing authors accurately reflect the rapidly evolving areas within surgical and medical specialties.
Raj Bawa, MS, PhD, MD '22, is president of Bawa Biotech LLC (founded in 2002), a biotech/pharma consultancy and patent law firm based in Ashburn, Virginia, USA. Trained as a microbiologist and biochemist, he is an inventor, entrepreneur, professor, and registered patent agent (since 2002) licensed to practice before the US Patent & Trademark Office. He is currently a scientific advisor to Teva Pharmaceutical Industries Ltd. (Israel), a visiting research scholar at the Pharmaceutical Research Institute of Albany College of Pharmacy (Albany, NY), and vice president/chief IP officer at Guanine, Inc. (Rensselaer, NY). He is also a medical student and will receive the MD degree in 2022. He has served as a principal investigator of various research grants, most recently as a principal investigator of a CDC grant to develop an assay for carbapenemase-resistant bacteria. He was an adjunct professor at Rensselaer Polytechnic Institute (Troy, NY) from 1998 to 2018, where he received his doctoral degree in three years (biophysics/biochemistry). In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office (Washington, DC), including primary examiner from 1996–2002. Presently, he is a life member of Sigma Xi, co-chair of the nanotech and precision medicine committees of the American Bar Association, and founding director of the American Society for Nanomedicine (founded in 2008). He has authored over 100 publications, co-edited 8 texts, and serves on the editorial boards of numerous peer-reviewed journals, including serving as an associate editor of Nanomedicine (Elsevier). Some of Dr. Bawa’s awards include the Innovations Prize from the Institution of Mechanical Engineers, London, UK; Appreciation Award from the Undersecretary of Commerce, Washington, DC; Key Award from Rensselaer’s Office of Alumni Relations; and Lifetime Achievement Award from the American Society for Nanomedicine.
Paul J. Davis, MD, is professor of medicine at Albany Medical College and adjunct professor of pharmacy at the Albany College of Pharmacy and Health Sciences, USA, He was selected as Top Endocrine Pharmacologist for 2018 by the International Association of Top Professionals (IAOTP) for his outstanding leadership and commitment to the profession. Dr. Davis directs a group of scientists who have defined molecular mechanisms for many nongenomic, plasma membrane-initiated actions of thyroid hormone, including actions on plasma membrane ion transporters, intracellular protein trafficking, phosphorylation of nuclear hormone receptors and of p53 and on transcription of specific genes. They have described the cell surface receptor for thyroid hormone on integrin avb3 and the actions of tetraiodothyroacetic acid (tetrac) and reformulated (nanoparticulate) tetrac initiated at this plasma membrane receptor that are anti-angiogenic and anti-cancer by multiple cell surface and intracellular pathways.
Jay K. Doshi, DDS, is president of Jay K. Doshi Dental Associates, PA, Spring, Texas, founded in 2009. He received his training from the University of Texas Houston dental branch. He has been in private practice since 2000. His practice caters to patients of all ages with an emphasis on preventative and all phases of cosmetic and restorative dentistry. He is a member of the American Dental Association, Texas Dental Association, and Greater Houston Dental Association. He also is a member of the prestigious Las Vegas Institute for Neuromuscular and Cosmetic Dentist.
Mario Ganau, MD, PhD, MBA, is a neurosurgeon and scientist with a wide breadth of knowledge in the application of innovation technology to clinical practice. Following formal medical and neurosurgical training in Italy and France, he completed post-CCT fellowships in UK and Canada, before joining the Department of Neurosurgery at Oxford University Hospitals in 2018. His academic curriculum includes a PhD in nanotechnology and a PhD in biomedical engineering, as well as economics studies at École Polytechnique Fédérale de Lausanne, Switzerland. Dr Ganau’s core scientific interest focuses on the diagnostic and theranostic aspects of nanomedicine. Additionally, during his tenure as a visiting researcher at the Kennedy Institute of Ethics, Georgetown University, USA, he explored the ethical impact of those innovations with the aim to enhance the quality of a comprehensive technology-based patient-centered approach. During this path at the forefront of clinical practice and basic research, he authored over 100 peer-reviewed articles and book chapters and edited books, which led him to receive several awards, recognitions, and accolades in Europe, North America, and Asia.
Publisher : Jenny Stanford Publishing; 1st edition (July 20, 2023)
Language : English
Hardcover : 1378 pages
ISBN-10 : 981487745X
ISBN-13 : 978-9814877459
